Insights

Strategic Positioning Rebrand from DOCS to ICON Strategic Solutions signals a refined focus on FSP services and a unified global platform. This presents an opportunity to position partnerships around integrated functional service delivery, cost savings, and enhanced clinical expertise for prospective pharma clients seeking scalable, compliant outsourcing.

Global Scale ICON Strategic Solutions emphasizes global leadership in FSP with combined functional, operational, and talent capabilities. Target large and mid-size pharmaceutical manufacturers looking to expand externalized function support across multiple regions while maintaining quality and speed to market.

Technology Enablement Adoption of modern tech stack including GitHub, SharePoint Online, NIST framework, Rapid7, and data tooling indicates a mature, security-conscious delivery model. Use this to reassure prospects about governance, cybersecurity, and collaborative workflows in outsourced programs.

Industry Recognition Extensive press coverage and investor context around Doximity and strategic AI initiatives underline a market focus on AI-enabled physician workflows. Leverage AI capabilities and validated clinical AI safety positioning to differentiate FSP offerings for clinically oriented pharma projects.

Market Fit Revenue scale hints at a mid-to-large client base with high needs in clinical operations and outsourced functions. Prioritize sales outreach to mid-to-large biotech and pharma companies seeking cost efficiency and faster delivery through proven FSP models.

DOCS Tech Stack

DOCS uses 8 technology products and services including Qlik, Microsoft 365 Copilot, Snowflake, and more. Explore DOCS's tech stack below.

Media & News

DOCS's Email Address Formats

DOCS uses at least 2 format(s):
DOCS Email FormatsExamplePercentage
First.Last@docsglobal.comJohn.Doe@docsglobal.com
97%
FLast@docsglobal.comJDoe@docsglobal.com
3%
First.Last@iconplc.comJohn.Doe@iconplc.com
93%
FirstLast@iconplc.comJohnDoe@iconplc.com
4%
First.L@iconplc.comJohn.D@iconplc.com
2%
Last.First@iconplc.comDoe.John@iconplc.com
1%

Frequently Asked Questions

What is DOCS's stock symbol?

Minus sign iconPlus sign icon
DOCS is a publicly traded company; the company's stock symbol is DOCS.

What is DOCS's official website and social media links?

Minus sign iconPlus sign icon
DOCS's official website is iconplc.com and has social profiles on LinkedIn.

How much revenue does DOCS generate?

Minus sign iconPlus sign icon
As of August 2026, DOCS's annual revenue is estimated to be $1B - $10B.

What is DOCS's NAICS code?

Minus sign iconPlus sign icon
DOCS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does DOCS have currently?

Minus sign iconPlus sign icon
As of August 2026, DOCS has approximately 735 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Clinical Research Associate Docs - Partner Of Amgen: N. G.Global Clinical Trial Manager (gctm) Contracted Partner Of Amgen: C. A.Owner: D. O.. Explore DOCS's employee directory with LeadIQ.

What industry does DOCS belong to?

Minus sign iconPlus sign icon
DOCS operates in the Pharmaceutical Manufacturing industry.

What technology does DOCS use?

Minus sign iconPlus sign icon
DOCS's tech stack includes QlikMicrosoft 365 CopilotSnowflakeFigmaBoomiSmartsheetCoupaPiwik PRO Core.

What is DOCS's email format?

Minus sign iconPlus sign icon
DOCS's email format typically follows the pattern of First.Last@docsglobal.com. Find more DOCS email formats with LeadIQ.
DOCS logo

DOCS

Pharmaceutical ManufacturingSouth Dublin, Ireland501-1000 Employees

ICON Strategic Solutions, formerly known as DOCS, operates as a global provider of Functional Service Provision (FSP) within the pharmaceutical sector. By combining functional, operational, and talent capabilities, it delivers FSP arrangements that can reduce costs, supply clinical expertise, and enhance overall business performance for its clients.

Based in South Dublin, Ireland, the unit is part of ICON plc and recently rebranded its DOCS FSP services to ICON Strategic Solutions, with ongoing activity moved to a dedicated brand page. Its customers are pharmaceutical and biotechnology developers seeking outsourced, scalable functional support to streamline development and operations. In the broader pharmaceutical development services market, ICON Strategic Solutions positions itself as a global, integrated FSP provider that aligns specialized know-how with operational delivery.

Section iconCompany Overview

Stock Symbol
DOCS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $1B - $10B

    DOCS's revenue is estimated to be in the range of $1B - $10B

Section iconFunding & Financials

  • $1B - $10B

    DOCS's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.